The estimated Net Worth of John C.K. Iv Milligan is at least $9.99 Milion dollars as of 10 May 2021. Mr. Milligan owns over 103,500 units of TherapeuticsMD Inc stock worth over $3,194,806 and over the last 13 years he sold TXMD stock worth over $5,359,221. In addition, he makes $1,440,640 as President a Secretary at TherapeuticsMD Inc.
Sign up
Mr. Milligan TXMD stock SEC Form 4 insiders trading
John has made over 33 trades of the TherapeuticsMD Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 103,500 units of TXMD stock worth $184,013 on 10 May 2021.
The largest trade he's ever made was selling 353,412 units of TherapeuticsMD Inc stock on 26 March 2014 worth over $2,367,860. On average, John trades about 92,290 units every 46 days since 2012. As of 10 May 2021 he still owns at least 1,796,955 units of TherapeuticsMD Inc stock.
You can see the complete history of Mr. Milligan stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Milligan biography
John C.K. Milligan IV serves as President, Secretary of the Company. Mr. Milligan served as President and director of VitaMed. Prior to VitaMed, Mr. Milligan co-founded CareFusion, LLC, serving as President and General Manager from August 2001 to February 2008, and then as President and Chief Operating Officer of CareFusion, Inc. From 1997 to 2001, Mr. Milligan was Vice President, Sales and Operations for Omnicell, Inc. Prior to Omnicell, Mr. Milligan also held executive management positions at Serving Software Inc. and HBO & Co., a health care information systems company, both of which were subsequently acquired by McKesson Corporation. Mr. Milligan is a graduate of the U.S. Naval Academy.
What is the salary of John Milligan?
As the President a Secretary of TherapeuticsMD Inc, the total compensation of John Milligan at TherapeuticsMD Inc is $1,440,640. There are no executives at TherapeuticsMD Inc getting paid more.
How old is John Milligan?
John Milligan is 57, he's been the President a Secretary of TherapeuticsMD Inc since 2020. There are 7 older and 19 younger executives at TherapeuticsMD Inc. The oldest executive at TherapeuticsMD Inc is Tommy Thompson, 78, who is the Independent Chairman of the Board.
What's John Milligan's mailing address?
John's mailing address filed with the SEC is 951 YAMATO ROAD, SUITE 220, , BOCA RATON, FL, 33431.
Insiders trading at TherapeuticsMD Inc
Over the last 13 years, insiders at TherapeuticsMD Inc have traded over $21,656,853 worth of TherapeuticsMD Inc stock and bought 721,732 units worth $2,299,099 . The most active insiders traders include Cooper C. Collins, Brian Bernick a Robert G Finizio. On average, TherapeuticsMD Inc executives and independent directors trade stock every 29 days with the average trade being worth of $272,607. The most recent stock trade was executed by John C.K. Iv Milligan on 25 October 2019, trading 72,000 units of TXMD stock currently worth $198,000.
What does TherapeuticsMD Inc do?
therapeuticsmd, inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. we create products to address the unique changes and challenges women experience through every stage of their lives. with momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. this includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitamedmd® and bocagreenmd® brands. see our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines
What does TherapeuticsMD Inc's logo look like?
Complete history of Mr. Milligan stock trades at TherapeuticsMD a TherapeuticsMD Inc
TherapeuticsMD Inc executives and stock owners
TherapeuticsMD Inc executives and other stock owners filed with the SEC include:
-
John Milligan,
President, Secretary -
Brian Bernick,
Co-Founder -
Robert Finizio,
Chief Executive Officer and Director -
Robert G. Finizio,
Co-Founder & Vice Chair -
Mitchell Krassan,
Chief Strategy and Performance Officer -
John C. K. Milligan IV,
Chief Exec. Officer of VitaCare Prescription Services -
Michael Donegan,
Vice President - Finance -
Tommy Thompson,
Independent Chairman of the Board -
Cooper Collins,
Independent Director -
J. Martin Carroll,
Independent Director -
Angus Russell,
Independent Director -
Jules Musing,
Independent Director -
Dr. Brian A. Bernick,
Co-Founder & Chief Scientific Officer -
Nichol Ochsner,
Vice President, Investor Relations -
Gail Naughton,
Independent Director -
Karen Ling,
Independent Director -
Paul Bisaro,
Independent Director -
Bharat Warrier,
Chief Manufacturing Officer -
Sebastian Mirkin,
Chief Medical Officer -
Dawn Halkuff,
Chief Commercial Officer -
Marlan Walker,
General Counsel -
John Knighton,
Chief Compliance Officer -
Adam Miller,
Chief Information Officer -
James D'Arecca,
Chief Financial Officer -
Julia M. Amadio,
Chief Product Officer -
Mitchell L. Krassan,
Exec. VP and Chief Strategy & Performance Officer -
Chris Gish,
Sr. VP of Sales -
Michael Donegan,
Chief Accounting Officer & VP of Fin. -
James C. D'Arecca,
Chief Financial Officer -
Hugh O'Dowd M.B.A.,
Pres, CEO & Director -
Robert V Jr La Penta,
Director -
Nicholas Segal,
Director -
Jane F Barlow,
Director -
Daniel A Cartwright,
Chief Financial Officer -
Randall S Stanicky,
Director -
Samuel A Greco,
Director